Neurodegeneration Biomarker Articles & Analysis
3 news found
THE ROCKIT-1 STUDY ROCKIT-1 is a phase 2a open-label study to assess preliminary safety, tolerability, and effect on neurodegeneration biomarkers of BRAVYL in patients with 4-Repeat (4R) Tauopathies to assess whether the drug improves clinical features of the disease. ...
The project is testing Cortical Disarray Measurement (CDM®) technology as a neurodegeneration biomarker with a view to using it in future clinical trials. ...
DiamiR, a developer of innovative blood-based diagnostic tests for neurodegenerative and other diseases, announced today a $492,000 award in support of the project entitled "Circulating brain-enriched microRNAs as peripheral biomarkers of neurodegeneration." The award will accelerate the development of DiamiR's targeted diagnostic technology for detection and ...
ByDiamiR